Current assays lack effective measurements for simultaneous analysis of the indandiones, especially the isomers. The intent of this study was to establish a novel and selective method for the simultaneous determination of indandione-type rodenticides (diphacinone, chlorophacinone, valone, and pindone) in human serum by liquid chromatography-electrospray ionization-tandem mass spectrometry. After addition of internal standard, the sample was extracted with 10% methanol in acetonitrile and cleaned by solid-phase extraction (SPE). The analytes were separated on a C 18 rapid column and infused into an ion trap mass spectrometer in the negative electrospray ionization mode. The multiple-reaction monitoring ion pairs were m/z 339 → → 167, m/z 373 → → 201, m/z 229 → → 145, m/z 229 → → 172, and m/z 307 → → 161 for diphacinone, chlorophacinone, valone, pindone, and IS, respectively. Recoveries were between 81.5 and 94.6%, and the limits of quantification were 0.2 to 0.5 ng/mL. Intra-and interday RSDs were less than 7.9 and 11.5%, respectively. The assay was linear in the range of 0.5-100.0 ng/mL with coefficients of determination (r 2 > 0.99) for all analytes. The proposed method enables the unambiguous confirmation and quantification of the indandiones in both clinical and forensic specimens.
Introduction
Indandione rodenticides were widely used to control populations of rats and mice in urban areas in China. The extensive use led to an urgent requirement for an analytical method in cases of suspected intoxication. In fact, because of their biological activity, indandione rodenticides might have detrimental effects on nontarget species such as domestic animals and human beings. Acute toxicity and chronic intoxication, resulting in death, were reported worldwide (1-3). Our laboratory often received biological samples from intoxication cases for confirmation of the presence of indandiones in biological samples.
The determination of trace levels of indandione anticoagulant rodenticides in serum is often confounded by the complexity of the background substances in these matrices. The main methods involved were spectrophotometry (4), gas chromatography (GC) (5), GC with mass spectrometry (MS) (6) , liquid chromatography (LC) (7) (8) (9) (10) (11) , LC-MS (12) (13) (14) , ion chromatography (IC)-MS (15) , and IC-MS-MS (16, 17) . The main problem with the spectrophotometric method was the lack of robustness and detection sensitivity, and the GC method required derivatization. Although a high-performance liquid chromatography (HPLC)-ultraviolet (UV) detection method was widely used for the determination of trace levels of diphacinone in biological samples, lower level residues and limited quantities of specimens would probably result in ambiguous confirmation of toxicological analyses because of its relative non-selectivity and insufficient sensitivity. As ion source technology has developed, the MS, in combination with LC, has been increasingly used in the identification and analysis of toxic compounds (18) (19) (20) (21) (22) (23) (24) (25) . Although both the IC-MS and IC-MS-MS methods had a wide application prospect in the analysis of stronger polar compounds, LC-MS-MS would be more practical to implement in the majority of toxicology laboratories. Even though some LC-MS and LC-MS-MS methods were reported to determine chlorophacinone alone or together with diphacinone or pindone, to the best of our knowledge, no method was reported for simultaneous determination and confirmation of all four indandione-type rodenticides (diphacinone, chlorophacinone, valone, and pindone, as shown in Figure 1 ) in human serum.
Tandem MS is an emerging technique with particular advantages in analysis of biological mixtures, especially compounds with poor chromatographic properties. MS-MS could
LC-ESI-MS-MS
The analytical method for development and validation was performed on an Agilent 1100 series LC-MSD Trap SL system (Agilent Technologies, Waldbronn, Germany), consisting of a quaternary pump (G1311A), a column thermostat (G1316A), a degasser unit (G1379A), an autosampler (G1313A), a diodearray detector (G1315B), and an ion trap MS with an electrospray ionization (ESI) interface. The LC-ESI-MS-MS system was controlled, and data were analyzed, on a computer equipped with LC-MSD Trap Software 4.2 (Bruker Daltonik GmbH). All tubing used for connection was PEEK (0.25-mm i.d., Agilent Technologies).
Chromatographic separation was performed on a Zorbax XDB C 18 column (30 mm × 2.1-mm i.d., 3-μm particle size, Agilent Technologies) using acetic acid/ammonium carbonate (5 mmol/L, pH 6.3)/MeOH (25:75, v/v) as mobile phase in isocratic mobile phase at a constant flow rate of 0.20 mL/min. The column was hold at a constant temperature of 35°C, and the injection volume was 20.0 μL.
The ion trap MS was used with an ESI interface in the negative mode with a full scan mass spectra over the range m/z 50-400 using a cycle time of 1 s, a peak width of 0.1 s, a capillary voltage of 2.8 kV, a capillary exit voltage of -165 V, a dry temperature of 325°C, a high purity nitrogen (99.999%) dry gas of 9.0 L/min, a nitrogen nebulizer pressure of 60.0 psi, and a dwell time of 200 ms. The ESI interface and MS parameters were optimized with the standards (100.0 µg/L for each) by a syringe pump via a T-connector in the infusion to obtain maximum sensitivity and stability. At the same time, the selection of ions and collision voltages were optimized using the LC-MSD trap software. Table I outlines the MRM parameters for diphacinone, chlorophacinone, valone, pindone, and IS. The MRM peak areas were integrated for quantification.
Calibration curve and quality control samples
Stock solutions of the five authentic standards were prepared by dissolving 1.0 mg of the analytes in 1.0 mL of methanol. These solutions were thoroughly mixed and stored at 4°C in tightly closed bottles until use. The stock solutions of diphacinone, chlorophacinone, valone, pindone, and IS were diluted with methanol to obtain working solutions of each substance at 0.2, 0.5, 1.0, 3.0, 5.0, 15.0, 50.0, and 100.0 ng/mL. To prepare calibration samples, the appropriate volumes of working solution were added to a 2-mL polypropylene centrifuge tube and evaporated to dryness under a gentle stream of nitrogen. The residues were then reconstituted with 500 μL of blank human serum to obtain diphacinone, chlorophacinone, valone, and pindone at 0.2, 0.5, 1.0, 3.0, 5.0, 15.0, 50.0, and 100.0 ng/mL, and the IS was at 50.0 ng/mL. Three replicate analyses were performed for each calibrator to evaluate linearity. The calibration curves were constructed by linear regression using the peak-area ratios of diphacinone, chlorophacinone, valone, and pindone to the IS, plotted against the corresponding concentrations.
A similar dilution procedure was used to prepare separate working solutions containing 2.0, 15.0, and 100.0 ng/mL diphacinone, chlorophacinone, valone, and pindone. These solutions were added to a 2-mL polypropylene centrifuge tube and were evaporated to dryness under a gentle stream of nitrogen. Then the residues were reconstituted with 500 μL of blank human serum to make quality control (QC) samples containing 2.0, 15.0, and 100.0 ng/mL diphacinone, chlorophacinone, valone, and pindone.
Sample preparation
Serum specimens (500 μL), including calibrator, qualitycontrol serum sample, or patient sample, were thawed to room temperature and added into a 2-mL labeled polypropylene centrifuge tube, and 5 µL (5.0 ng/mL) IS and 1.0 mL 10% methanol in acetonitrile were pipetted into each sample. The tubes were vortex mixed on the Vortex-Genie ® 2 (Scientific Industries, Bohemia, NY) for 5 min. After centrifugation for 5 min at 7800 rpm, the upper organic layer was transferred to a disposable glass tube, and liquid-liquid extraction was repeated. The organic layer was combined and evaporated to dryness under a stream of nitrogen on a heating block at 50°C in a disposable glass tube.
The residues were redissolved in 2.0 mL of MeOH/water (80:20, v/v) by ultrasonication for 5 min, and then uploaded on an Oasis HLB (200 mg, Waters) cartridge which had been conditioned sequentially with 4.0 mL dichloromethane, 4.0 mL MeOH, and 5.0 mL water. The flow rate of the sample was 5.0 mL/min. The elution was used with 5.0 mL MeOH and 5.0 mL dichloromethane, then evaporated to dryness by a gentle stream of nitrogen, and the residues were reconstituted with 500 μL of mobile phase. The sample was mixed with a vortex mixer, then sonicated for 3 min, and filtered through a 0.20-μm PTFE syringe filter (Agilent Technologies); a 20-μL aliquot was directly injected into the LC system.
Ion suppression and extraction efficiency
The extraction efficiency was determined experimentally at concentrations of 2.0, 15.0, and 100.0 ng/mL for diphacinone, chlorophacinone, valone, and pindone. The extraction efficiency for the IS was determined at a concentration of 50.0 ng/mL. The absolute extraction recoveries were evaluated by comparing the analyte peak areas obtained from the supplemented serum samples to those obtained from the corresponding unextracted calibrators prepared at the same concentrations (n = 5).
The degree of ion suppression that could be attributed to the sample matrix was estimated in a separate set of experiments. Blank serum samples were extracted as described, and the derived methanolic eluants were supplemented with 2.0, 15.0, and 100.0 ng/mL for diphacinone, chlorophacinone, valone, and pindone. Ion suppression was calculated by comparing analyte peak areas obtained from pure methanolic preparations with those obtained from supplemented serum samples after extraction (n = 5).
Precision and accuracy
To investigate the accuracy of the method, five replicates of three serum samples fortified with different concentrations (2.0, 15.0, and 100.0 ng/mL) were extracted and analyzed independently on three days to evaluate intraday variation. The samples were extracted and analyzed in triplicate on 8 separate days within a 14-day period to evaluate the interday variation.
Results and Discussion

MS-MS measurement and development
The MS-MS spectra obtained by direct infusion of 100.0 ng/mL diphacinone, chlorophacinone, valone, pindone, and IS are shown in Figure 1 . These spectra were acquired by transmitting the deprotonated molecular ion via CID and scanning the product ions in the ion trap. The autotune program provided in the system software was used to optimize the instrument for transmission of the deprotonated molecular ion and for maximum intensity of the selected fragment. These results were used to design the MRM experiments for the sequential transitions of m/z 339 → 167 for diphacinone, m/z 373 → 201 for chlorophacinone, m/z 229 → 172 for pindone, m/z 229 → m/z 145 for valone, and m/z 307 → 161 for IS. Figure 2 showed representative MRM chromatograms of a control serum prepared and subjected to LC-ESI-MS-MS analysis as described in the Experimental section. Elution times were 2.4, 3.3, 3.9, 4.7, and 5.5 min for diphacinone, chlorophacinone, IS, valone, and pindone, respectively. The total LC-MS-MS analysis time was less than 7 min per sample. No interferences of the analytes were observed because of the high selectivity of the MS-MS technique.
LC separation
The aim of this work was for the separation and quantification of chlorophacinone, diphacinone and the chain isomers of valone and pindone in the serum. The problems for separation of valone and pindone were with their rather similar chemical properties and chromatographic characteristics. Both had the two product ions of m/z 172 and m/z 145 from the precursor ion m/z 229, with the only difference being the ratio of the intensity. To develop a robust and suitable LC method for the separation of chain isomers of valone and pindone, different mobile phases and stationary phases were employed. In the preliminary experiments, separation used reversed-phase columns such as C 18 and C 8 of various makes and different mobile phases were used. However, in the most of these trials chlorophacinone, diphacinone and the chain isomers of valone and pindone could not be well separated. Fortunately, in an attempt to change the pH of the mobile phases consisting of acetic acidammonium carbonate (5 mmol/L, pH 6.3)/MeOH (25:75, v/v) using a Zorbax XDB C 18 column (30 mm × 2.1-mm i.d., 3-μm particle size), the separation was successfully achieved, especially, with a good resolution for the chain isomers of valone and pindone. The retention times of diphacinone, chlorophacinone, IS, valone, and pindone were 2.4, 3.3, 3.9, 4.7, and 5.5 min, respectively, as shown in Figure 2 . Even if a small amount of valone in the presence of a relatively high concentration of pindone, or vice versa, this method performed well.
Measurement validation
The assay was validated in accordance with Food and Drug Administration guidelines (26) . The peak-area ratio (Y, indandiones/IS) was then used in conjunction with the calibration curve to derive the concentration (C, ng/mL) in serum samples. The calibration curve was linear over the ranges 0.5-100 ng/mL for diphacinone, chlorophacinone, and pindone and 0.2-100 ng/mL for valone, as determined by three separate measurements. The coefficient of linear correlation (r 2 ) was > 0.99 for the calibration curves of the four compounds with the slope and intercept of less than 4.4% and 4.0%, respectively, as shown in Table II . The limits of quantification were established by a serial extraction of serum samples containing decreasing concentrations of the analytes. The limits of quantification were 0.5, 0.5, 0.2, and 0.5 ng/mL for diphacinone, chlorophacinone, valone, and pindone, respectively (mean signal-to-noise ratio = 10).
The intraday precision was evaluated by performing five replicates each day within three days for the determination of three spiked QC samples (2.0, 15.0, and 100.0 ng/mL) including extraction procedures. The intraday precisions (RSD) on the basis of peak area were less than 7.8, 7.4, 7.9, and 7.8% for diphacinone, chlorophacinone, valone, and pindone, respectively, as shown in Table III. 297 Table II The interday precision was also evaluated by performing duplicates of three spiked QC samples (2.0, 15.0, and 100.0 ng/mL) including extraction procedures on each of 8 different days within a 14-day period. Interday precisions (RSD) on the basis of peak area were less than 8.4, 7.9, 11.5, and 9.8% for diphacinone, chlorophacinone, valone, and pindone, respectively, as shown in Table III .
The recoveries were estimated by external standard calibration with QC samples (2.0, 15.0, and 100.0 ng/mL). The recoveries were between 84.5 and 94.6%, 87.5 and 89.0%, 82.3 and 88.5%, and 81.5 and 92.2% for diphacinone, chlorophacinone, valone, and pindone, respectively, as shown in Table III .
The efficiency of ionization was estimated by comparing analyte peak areas (n = 5) obtained from pure methanolic preparations with those obtained from serum samples supplemented with an equivalent amount of each analyte after extraction. The decreases in peak area with QC samples (2.0, 15.0, and 100.0 ng/mL) were less than 5.9% for diphacinone, less than 4.3% for chlorophacinone, less than 5.8% for valone, less than 3.8% for pindone, and less than 4.7% for the IS.
In order to determine the influence of temperature on the stability of diphacinone, chlorophacinone, valone, and pindone in serum, the QC samples were analyzed under different condition in three replicates. After three freeze-and-thaw cycles (room temperature to −20°C) were performed for three concentrations (2.0, 15.0, and 100.0 ng/mL), the percent bias was between −2.2 and −8.7% in comparison with freshly prepared samples. Benchtop stability for 24 h was tested at three concentrations (2.0, 15.0, and 100.0 ng/mL), and the percent bias calculated by comparing with freshly prepared sample was found to be between −3.7 and −8.7%, as shown in Table IV .
Applicability
The MRM chromatogram obtained from an extracted serum sample taken from a patient with an increased clotting time, who acknowledged taking a rodenticide but did not know what type it was, is shown in Figure 3A . Both tetramine and fluoroacetamide were clearly excluded by the clinical symptoms, and diphacinone was unambiguously identified and quantified at 1847 ± 34 ng/mL (accurately determined by decuple dilution with methanol to the linear range of diphacinone, n = 6) in sample A. The LC-MS-MS analysis of an extracted serum sample of another patient, who experienced bleeding from the urinary tract during therapy with pindone, is shown in Figure 3B . The measured serum pindone concentration was 3.7 ± 0.14 ng/mL for sample B (n = 6).
In addition, we used our previously developed IC-MS method (15) for the determination of the two samples. The results were 1746 ± 28 ng/mL for sample A and 3.8 ± 0.15 ng/mL for sample B (n = 6). In a comparison of the two groups of data, there is no significant difference for sample A and sample B.
Conclusions
An LC-MS-MS assay for the quantification of indandionetype rodenticides (diphacinone, chlorophacinone, valone, and pindone) in human serum was developed and validated. The novel method was rapid, sensitive, specific, selective, and precise, and it can be applied to the analysis of the indandiones in serum for clinical diagnosis and forensic toxicology. 
